HIM
Hillhouse Investment Management Portfolio holdings
AUM
$3.13B
1-Year Est. Return
8.17%
1 Year Est. Return
-8.17%
AUM
$2.4B
AUM Growth
+$1.06B
(+79%)
Holding
33
Top Buys
| 1 | +$248M | |
| 2 | +$149M | |
| 3 | +$109M | |
| 4 |
Gossamer Bio
GOSS
|
+$108M |
| 5 |
Amazon
AMZN
|
+$42.5M |
Sector Composition
| 1 | Communication Services | 38.75% |
| 2 | Consumer Discretionary | 26.81% |
| 3 | Healthcare | 20.31% |
| 4 | Financials | 11.33% |
| 5 | Technology | 1.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Goldman Sachs
GS
$237B
| $10.2M | 0.43% |
+53,300
|
|
||
|
XYZ
27
Block Inc
XYZ
$44.2B
| $10.2M | 0.42% |
+135,500
|
|
||
|
TCRR
28
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $5.63M | 0.23% |
+322,903
|
|
||
29
Apollo Global Management
APO
$74.7B
| $4.56M | 0.19% |
161,437
+123,759
|
|
||
|
CNST
30
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $4.31M | 0.18% |
317,921
|
|
||
31
Arcus Biosciences
RCUS
$2.14B
| $4.27M | 0.18% |
342,128
|
|
||
32
Arvinas
ARVN
$700M
| $3.4M | 0.14% |
230,308
|
|
||
|
NTGN
33
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| $2.58M | 0.11% |
399,308
|
|